Abstract
The chemokine receptor, CCR2, is predominantly expressed on monocytes/macrophages, and on a subset of memory T cells. It binds to several CC type chemokines of the monocyte chemoattractant protein (MCP) family of which MCP-1 exhibits the highest affinity. CCR2/MCP-1 expression/association in monocyte/macrophage/T cells has been associated with inflammatory processes such as rheumatoid arthritis, multiple sclerosis and atherosclerosis. Neutralization of CCR2 with either a peptide or receptor antagonist results in the prevention of joint swelling in rodent models of arthritis. In this paper, bioassay-guided discovery of CCR2 receptor antagonists derived from natural product extracts are reported. These antagonists belong to two main classes exemplified by bis-thiodiketopiperazines and cytochalasins. Six compounds, including emestrin, two new emestrin analogs, and chaetomin represent the first group of compounds. These compounds inhibited the binding of MCP-1 to CCR2 (CHO membrane) with IC50 values of 0.8 to 9 µM and exhibited good activity in a whole cell assay using MCP-1 and human monocytes with IC50′S ranging from 4∼9 µM. Cytochalasins A and B represented the second group and inhibited the binding activity with IC50 values of 5 and 188 µM, respectively. This is the first report of natural product antagonists of the CCR2 receptor.
Similar content being viewed by others
Article PDF
References
Ley K . Arrest, migration, survival, and proliferation of leukocytes and vascular cells: The many faces of chemokine biology. Microcirculation 10: 245–246 ( 2003)
Daly C, Rollins BJ . Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies. Microcirculation 10: 247–257 ( 2003)
Charo IF, Peters W . Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell proliferation. Microcirculation 10: 259–264 ( 2003)
Rose CE, Jr, Sung SSJ, Fu SM . Significant involvement of CCL2 (MCP1) in inflammatory disorders of the lung. Microcirculation 10: 273–288 ( 2003)
Cascieri MA, Springer MS . The chemokine/chemokine-receptor family: Potential and progress for therapeutic intervention. Curr Opin Chem Biol 4: 420–427 ( 2000)
Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I . An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186: 131–137 ( 1997)
Brodmerkel CM, Collins R, Hall L, Hertel D, Stewart R, Wang A, Xue CB, Diamond S, Friedman S, Vaddi K . In 68th Annual Meeting of American College of Rheumatology, San Antonio, Texas, 2004
Seya H, Nozawa K, Nakajima S, Kawai K, Udagawa S . Studies on fungal products. Part 8. Isolation of structure of emestrin, a novel antifungal macrocyclic epithiodioxopiperazine from Emericella striata. X-ray molecular structure of emestrin. J Chem Soc Perkin Trans 1 1986: 109–116 ( 1986)
Ooike M, Nozawa K, Kawai KI . An epitetrathiodioxopiperazine related to emestrin from Emericella foveolata. Phytochemistry 46: 123–126 ( 1997)
Nozawa K, Udagawa S, Nakajima S, Kawai K . Studies on fungal products. XIV. Emestrin B, a new epithrithiodioxopiperazine, from Emericella striata. Chem Pharm Bull 35: 3460–3463 ( 1987)
Onodera H, Hasegawa A, Tsumagari N, Nakai R, Ogawa T, Kanda Y . MPC1001 and its analogues: New antitumor agents from fungus Cladorrhinum species. Org Lett 6: 4101–4104 ( 2004)
Cole RJ, Cox RH . Handbook of Toxic Fungal Metabolites. Academic Press, New York ( 1981).
Ueno Y, Umemori K, Nimi E, Tanuma S, Nagata S, Sugamata M, Ihara T, Sekijima M, Kawai K, Ueno I . Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 humna promyelotic leukemia cells. Nat Toxins 3: 129–137 ( 1995)
Terao K, Ito E, Kawai K, Nozawa K, Udagawa S . Experimental acute poisoning in mice induced by emestrin, a new mycotoxin isolated from Emericella species. Mycopathologia 112: 71–79 ( 1990)
Ishikawa J, Okano J, Ohki K, Amagai A, Maeda Y, Miyata H . Phagocytosis of Dictyostelium discoideum studied by the particle-tracking method. Exp Cell Res 288: 268–276 ( 2003)
von-Wolff M, Ursel S, Hahn U, Steldinger R, Strowitzki T . Glucose transporter protiens (GLUT) in human endometrium: Expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metabol 88: 3885–3892 ( 2003)
Wndhaber RAJ, Wilkins RJ, Meredith D . Functional characterization of glucose transport in bovine articular chondrocytes. Pflügers Archiv Eur J Physiol 446: 572–577 ( 2003)
Hagglund CL, Gottschalk I, Lundahl P . Cytochalasin B-binding and transport properties of the Glut1 human red cell glucose transporter. Recent Res Dev Bioenerget 1: 117–129 ( 2000)
Ondeyka J, Hensens OD, Zink D, Ball R, Lingham RB, Bills G, Dombrowski A, Goetz M . L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease II. Isolation and structure. J Antibiot 45: 679–685 ( 1992)
Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, Plachw J, Stangassinger M, Erfle V, Schlondorff D . Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6: 769–775 ( 2000)
Gribble AD, Forbes IT, Witherington J . Preparation of 3-subsituted indoles or fused pyrroles as antagonists of the chemokine MCP-1 (CCR2B) receptor. GlaxoSmithKline, 2002, WO 2002079151 A1.
Yang L, Butora G, Parsons WH . Preparation of N-cyclopentylpiperidines as modulators of chemokine receptor activity. Merck & Co., Inc., 2002, WO 2002013824 A1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herath, K., Jayasuriya, H., Ondeyka, J. et al. Isolation and Structures of Novel Fungal Metabolites as Chemokine Receptor (CCR2) Antagonists. J Antibiot 58, 686–694 (2005). https://doi.org/10.1038/ja.2005.94
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2005.94
Keywords
This article is cited by
-
Non-lipopeptide fungi-derived peptide antibiotics developed since 2000
Biotechnology Letters (2019)